glp 1 fda compounding regulators, customs officers, and physicians around the world are continuing to raise alarms about unsafe and unregulated weight-loss and peptide products. An FDA warning letter to ProRx states the company continued 🚨 FDA Moves to Shut

But researchers have noticed that GLP-1 receptor agonists also have systemic effects beyond blood sugar and appetite, including anti-inflammatory properties

Many patients see a significant reduction in their LDL cholesterol within the first few weeks of starting treatment

The models performance on the training set, indicated by the red lines, keeps improving and saturates to near-perfect scores (~ 0.991.00) around epoch 20, indicating that the model is learning the training set

This, in combination with the blood sugar-lowering effects of GLP-1 medications can make your blood sugar drop too low (especially if you're taking other diabetes medications), making it dangerous

Not recommended during pregnancy or while breastfeeding

We have a med adherence problem